Physician

Hematology

Dr. Leonardo N. Faoro, MD

Leonardo Faoro practices Hematology. Leonardo Faoro is a published doctor and has 20 publications published. The lastest was: 'The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.'

Publications

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade ...
Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non-Small-Cell Lung Cancer, A Phase II Trial.
Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.
Generation of comprehensive thoracic oncology database--tool for translational research.
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untre...
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer.
MET receptor tyrosine kinase.
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Lymphatic vessel density is not associated with lymph node metastasis in non-small cell lung carcinoma.
Protein kinase C beta in malignant pleural mesothelioma.
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and ...
C. elegans as a model organism for in vivo screening in cancer: effects of human c-Met in lung cancer affect C. elegans vulva phenotypes.
Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.

Doctors Specialties

Medical Oncology
Oncology
Hematology

Accepted Insurances

Education

University of Chicago
Mayo School of Graduate Medical Education
Federal University of Parana Faculty of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Adam M. Petrich, MD This Doctor is OpenDoctor Recommended.
	Dr. Asha R. Dhanarajan, MD This Doctor is OpenDoctor Recommended.
	Dr. Seshan Subramanian, MD This Doctor is OpenDoctor Recommended.
	Dr. Justin P. Kline, MD This Doctor is OpenDoctor Recommended.
	Dr. Melissa L. Larson, MD
	Dr. Leonard A. Kosova, MD This Doctor is OpenDoctor Recommended.
	Dr. Shweta Gupta, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard G. Ghalie, MD